ArticleClinical genitourinary cancer2025

Off-Label Use of First-Line Immunotherapy for Metastatic Renal Cell Carcinoma.

Hannah D McManus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.